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The prediction of successful recanalization following thrombolytic or endovascular treatment may be 
helpful to determine the strategy of recanalization treatment in acute stroke. Thrombus can be de-
tected using noncontrast computed tomography (CT) as a hyperdense artery sign or blooming artifact 
on a T2*-weighted gradient-recalled image. The detection of thrombus using CT depends on slice 
thickness. Thrombus burden can be determined in terms of the length, volume, and clot burden score. 
The thrombus size can be quantitatively measured on thin-section CT or CT angiography/magnetic 
resonance angiography. The determination of thrombus size may be predictive of successful recanali-
zation/non-recanalization after intravenous thrombolysis and endovascular treatment. However, cut-
offs of thrombus size for predicting recanalization/non-recanalization are different among studies, 
due to different methods of measurements. Thus, a standardized method to measure the thrombus is 
necessary for thrombus imaging to be useful and reliable in clinical practice. Software-based mea-
surements may provide a reliable and accurate assessment. The measurement should be easy and 
rapid to be more widely used in practice, which could be achieved by improvement of the user inter-
face. In addition to prediction of recanalization, sequential measurements of thrombus volume before 
and after the treatment may also be useful to determine the efficacy of new thrombolytic drugs. This 
manuscript reviews the diagnosis of thrombus, prediction of recanalization using thrombus imaging, 
and practical considerations for the measurement of thrombus burden and density on CT.
Keywords Thrombus, Imaging, Tomography, X-ray computed, Therapeutic thrombolysis,
Endovascular procedure
REVIEW
Introduction
Imaging studies, including computed tomography (CT) and 
magnetic resonance imaging (MRI), are essential for the diagno-
sis and treatment of patients with acute stroke. Imaging meth-
ods in stroke have been developed and evolved for the accurate 
diagnosis of infarction/hemorrhage and arterial occlusion and 
the assessment of perfusion and collateral circulation. Since the 
successful introduction of reperfusion therapy in stroke, one of 
the key issues has been the selection of patients who would 
benefit from the recanalization therapy.1,2 Thus, the development 
and use of imaging techniques in acute stroke have been fo-
cused on identifying the presence and extent of potentially sal-
vageable areas upon recanalization and the durability of isch-
emic areas until recanalization. This imaging strategy has also 
been used for patient selection in several major clinical trials.3-6 
However, to rescue the salvageable areas, the occluded artery 
should be opened after recanalization treatment. Meanwhile, fa-
vorable clinical outcomes are not achieved in many patients 
treated with intravenous (IV) tissue plasminogen activator (tPA) 
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or endovascular treatment.7-9 Therefore, the prediction of suc-
cessful recanalization following thrombolytic or endovascular 
treatment is important. This prediction may also be helpful in 
determining the recanalization treatment strategy. 
Imaging methods for the diagnosis of stroke and salvageable 
areas target the brain tissues and arteries. However, the throm-
bus is the ultimate target of recanalization treatment. In this re-
gard, thrombus imaging evaluation is essential for predicting the 
response to IV tPA or endovascular treatment.10 Various preclini-
cal and clinical studies on direct thrombus imaging have been 
introduced in a recent review.11 While the thrombus can be de-
tected using noncontrast CT (NCCT), gradient-recalled echo 
(GRE), and susceptibility-weighted imaging (SWI) in humans 
(Supplementary Figure 1), most studies that investigated the pre-
diction of thrombus imaging for recanalization have been per-
formed using CT. Compared to MRI, CT is more easily and widely 
used, and CT-based thrombus imaging provides more precise in-
formation on thrombus burden. Furthermore, the density (Houn-
sfield unit [HU]) may represent the characteristics/composition of 
the thrombus to some extent. Recently, as endovascular throm-
bectomy has been more widely used for acute stroke, we can ob-
tain the thrombi occluding the intracranial arteries and know 
more about their histological characteristics and relationship 
with thrombus densities on CT.
This manuscript reviews the imaging diagnosis of thrombus on 
CT, prediction of recanalization using CT-based thrombus imag-
ing, methods for the quantitation of thrombus burden and den-
sity on CT, and histological and imaging characteristics of throm-
bus in acute stroke.
Detection of the thrombus
Thrombus is detected on NCCT as a hyperdense artery sign. 
The diagnosis of thrombus on NCCT depends on the slice thick-
ness. Conventional CT using 5- or 10-mm slice thickness has a 
limitation in displaying thrombi in the intracranial arteries, in-
cluding the MCA, which has a diameter <3 mm.12 In 51 patients 
with infarction in the middle cerebral artery (MCA) or anterior 
cerebral artery (ACA) territory, thrombi were identified in 45 pa-
tients (88%) on thin-section (1.25- or 1-mm thickness) NCCT, 
but only in 16 patients (31%) on standard 5-mm NCCT.13 This 
finding was replicated by another study that compared the de-
tection of clot between 5-mm NCCT and 0.625-mm NCCT in 54 
patients with MCA occlusion.14 The thin-section NCCT is sensi-
tive, reliable, and accurate for the detection of thrombi.15 
Prediction of recanalization based on 
thrombus size
Prediction in intravenous tPA thrombolysis
Recanalization rates after IV tPA in stroke depend on the loca-
tion of the occluded cerebral arteries. IV tPA-induced recanaliza-
tion is achieved more frequently in the MCA M2 occlusion than 
in the proximal MCA or the internal carotid artery occlusion.16,17 
Thrombus volume differs according to the location of occluded 
arteries. For example, the average thrombus volume is largest in 
the internal carotid artery occlusion, followed by MCA M1 and 
MCA M2 occlusion.18 Thus, thrombus volume may be a critical 
factor for successful recanalization in patients with acute stroke 
treated with IV tPA.
Several studies investigated whether the determination of 
thrombus size can predict successful recanalization/non-recana-
lization after IV tPA treatment in patients with stroke (Table 1). 
Kim and colleagues first investigated the association between 
successful recanalization and thrombus volume, which was 
measured automatically using a 3-dimensional imaging soft-
ware, in 34 patients with MCA occlusion.19 This study included 
patients who were treated with IV tPA or IV tPA plus intra-arte-
Table 1. Thrombus burden and recanalization (IV thrombolysis)
Author (year) Patient No. Artery
Imaging 
(CT thickness, mm)
Method Association with recanalization
Kim, 200619 8 MCA NCCT (1.25) Volume No (58.8±52.7 vs. 44.36±66.5, P=0.564)*
Riedel, 201120 138 Not specified NCCT (2.5) Length Yes (cut-off 8 mm, P<0.001) 
Shobha, 201321 41 M1 NCCT (5.0) Length Yes (86% vs. 37% vs. 0%, P<0.001)†
Behrens, 201422 96 Any intracranial CTA, MRA Length Yes (OR 0.78, 95% CI 0.65-0.95, P=0.014)‡
No recanalization in thrombus >16 mm 
Rohan, 201423 80 M1 CTA Length Yes (cut-off 12 mm, sensitivity 0.67, specificity 
0.71, OR 4.81, 95% CI 1.86-12.40)
Strbian, 201424 103 BA CTA, MRA Length Yes (15 [6-25] vs. 5.5 [3.6-15.4], P<0.001)
CT, computed tomography; MCA, middle cerebral artery; NCCT, noncontrast computed tomography; CTA, computed tomography angiography; MRA, magnetic 
resonance angiography; OR, odds ratio; CI, confidence interval; BA, basilar artery. 
*Recanalization vs. nonrecanallization, mm3; †thrombus length <10 mm vs. 10-19 mm vs. 20 mm, percent for the disappearance of hyperdense artery sign on 
follow-up scan; ‡decreased probability of recanalization per mm.
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rial (IA) urokinase, and no association was found between the 
thrombus volume and recanalization. Negative association in 
this study might be ascribed to the small sample size and the use 
of heterogeneous recanalization treatment modalities. In the 
subsequent studies, thrombus length was determined on NCCT 
or maximum intensity projection images using CT angiography 
(CTA)/MR angiography (MRA), and the length of thrombus was 
significantly associated with successful recanalization after IV 
tPA treatment.20-24 They attempted to determine the optimal cut-
off for predicting non-recanalization. However, the optical cut-
off was different among studies varying from 8–16 mm (Table 
1). Furthermore, they evaluated recanalization at different time 
points after IV tPA infusion.19 
Prediction in endovascular treatment
The association between thrombus size and successful recana-
lization after endovascular treatment has also been investigated. 
The results of the studies were inconsistent (Table 2). It might be 
because of the different mechanical devices used, different 
methods used to determine thrombus size, and small number of 
cases included.21,25-30 However, in a recent study of a relatively 
large number of patients who were treated with a stent retriever, 
higher clot burden scores were associated with increased likeli-
hood of recanalization.2 Smaller thrombi may be more easily re-
trieved with fewer attempts using a Solitaire device. However, 
the predictability of thrombus size for successful recanalization 
seems less remarkable in endovascular treatment than in IV tPA 
treatment. 
Practical considerations for the 
measurement of thrombus size 
Thrombus volume
Thrombus size can be determined in terms of volume, length, 
or burden score (Table 3). The thrombus volume is measured us-
ing imaging analysis software.18,31 This software-based measure-
ment of thrombus volume provides the most accurate and reli-
able information on thrombus burden, irrespective of the angio-
architecture. Rapid and easy measurements of thrombus volume 
and density are now feasible using a 3-dimensional software. 
Briefly, after the detection of thrombus on NCCT via the process 
of pixel pigmentation, a region of interest (ROI) is defined within 
any portion of thrombus using a brush tool. Then, automatic re-
gion growing is performed in the range of HU 40-100, and the 
volume and mean HU are automatically calculated and shown. 
This software may be used in emergent situations.32 
Thrombus length on noncontrast CT
Thrombus length can also be used to estimate the thrombus 
size. The accurate determination of thrombus length on standard 
Table 2. Thrombus burden and recanalization (endovascular treatment)
Author (year)
Patient 
No. 
Artery
Primary treatment 
modality
Imaging 
(CT thickness, mm)
Method Association with recanalization*
Kim, 200619 12 MCA IAT NCCT (1.25) Volume No (39.2±37.4 vs. 123.5±169.1, P=0.2)*
14 IVT+IAT No (106.1±94.5 vs. 79.2±61.8, P=0.482) *
Spiotta, 201425 122 MCA Penumbra, CTA Length No (13.3±10.0 vs. 13.5±7.6, P=0.92)*
Shobha, 201321 35 M1 Not specified NCCT (5.0) Length Yes (60% vs. 33% vs. 50%, P<0.002)†
Mokin, 201426 41 ICA, M1, M2 Solitaire NCCT (5.0) No 
CBS 6.6±1.1 vs. 6.6±1.8, P=0.87
Volume, 101.0±81.0 vs. 89.8±65.0, P=0.43
Length 12.2±4.7 vs. 14.0±6.0, P=0.44
Jindal, 201427 28 M1, ICA Penumbra, Solitaire, 
   Trevo
SWI, CTA, NCCT length No, P=0.378
Soize, 201528 153 Any intracranial Solitaire GRE Length 15.4±8.4 vs. 20.1±9.0, P=0.00003, cut-off 
18 (sensitivity 0.70, specificity 0.57, OR 3.09)
Angermailer, 2016 63 MCA, ICA Stent retriever CTA CBS No (7 [6-8] vs. 6 [4.5-7.0], P=0.08)
Mokin, 2016 69 MCA, ICA Solitaire CTA CBS No (6.5±1.7 vs. 7.3±1.3, P=0.25)
Treurniet, 2016 499 MCA, ICA Solitaire CTA CBS Yes (model A: OR, 1.25, 95% CI, 1.13-1.81, 
model B: OR 1.27, 95% CI, 1.14–1.41)‡
Values are mean±standard deviation, median [interquartile range], or odds ratio (OR) with 95% confidence interval (CI).
The volume is presented as mm3, and the length is presented as mm. 
CT, computed tomography; MCA, middle cerebral artery; IAT, intra-arterial thrombolysis; NCCT, noncontrast computed tomography; IVT, intravenous throm-
bolysis; ICA, internal carotid artery; M1, M1 segment of MCA; CTA, computed tomography angiography; SWI, susceptibility-weighted imaging; GRE, gradient-
recalled echo; CBS, clot burden score.
*Recanalization (TICI≥2) vs. nonrecanallization (TICI<2); †thrombus length <10 mm vs. 10-19 mm vs. 20 mm, percent for the disappearance of hyperdense 
artery sign on follow-up scan; ‡odds ratio (OR) and 95% confidence interval (CI) based on two different statistical models.
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Table 3. Methods to measure the thrombus size and burden
Volume 
Length
Clot burden score 
On NCCT On angiography
Imaging tool Thin-section NCCT Thin-section NCCT CTA, MRA CTA, MRA
Thrombus measurement Direct Direct Indirect based on absence of 
contrast opacification
Indirect based on absence of 
contrast opacification
Measurement method Pixel segmentation, region 
    growing, and automatic 
calculation using 3-dimen-
sional imaging software 
Pixel segmentation and 
    Euclidean length measure-
ment after reducing to 
skeleton using software
Measurement using free- 
    hand curve function on MIP 
image after post processing 
procedure
Visual scoring based on 
    determining the absence of 
contrast opacification in the 
predefined locations 
Measurable artery  Any intracranial artery Usually proximal segment of 
   intracranial artery
Any intracranial artery Anterior circulation
Accuracy Close to actual thrombus 
   burden (volume)
Close to actual thrombus 
   length
Can be overestimated Approximate burden
Can be overestimated
Practical use Requires software Requires software Requires postprocessing Easy and rapid by visual 
   assessment
NCCT, noncontrast computed tomography; CTA, computed tomography angiography; MRA, magnetic resonance angiography; MIP, multiple projection images.
Figure 1. A representative case for the measurement of thrombus length. Hyperdense artery sign is seen on thin-section noncontrast computed angi-
ography (CT) scan (arrows) (A). Measurement of thrombus length on this plain CT is almost impossible (A). An imaginary line (green dotted line) is 
drawn to measure the length on CT angiography (B, C). The actual location of the thrombus (D), which was visualized using 3-dimensional software 
(E), was superimposed on the imaginary lines of the actual angioarchitecture based on the angiographic findings after successful retrieval of thrombi 
using Solitaire stent (F). The thrombus length is overestimated on CT angiography, and thrombus in the bifurcated branch cannot be measured (D). 
A
B C D
E F
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NCCT is very difficult (Figure 1A), and depends on the slice thick-
ness of the CT scan. Accordingly, the length is first determined on 
thin-section NCCT via image processing procedures: pixel seg-
mentation, region growing, reducing to a skeleton by applying a 
topography-preserving morphological thinning operation, and cal-
culation of the maximum Euclidean length of the resulting skele-
ton.12 Based on this method, a thrombus length of 8 mm on 2.5-
mm NCCT was suggested as a cut-off of predicting non-recanali-
zation after IV tPA treatment.20 In fact, the THERAPY trial (The 
Randomized, Concurrent Controlled Trial to Assess the Penumbra 
System’s Safety and Effectiveness in the Treatment of Acute 
Stroke), which tested the effect of aspiration thrombectomy, in-
cluded a thrombus length of 8 mm or longer as inclusion criteria.33 
Thrombus length on CT angiography
Thrombus length may be measured on CTA, MRA, delayed 
gadolinium-enhanced T1 image, or SWI.34,35 The freehand curve 
function is used to measure thrombus length on maximum in-
tensity projection (MIP) images.23 The measurements on CTA or 
MRA are based on an arbitrarily drawn line in the absence of in-
formation on the actual angioarchitecture. Determination of the 
distal end of thrombus is dependent on the backflow from col-
lateral circulation. Thus, the length on CTA or MRA cannot be 
adequately measured in cases that lack the backflow and is 
therefore frequently overestimated. Obtaining delayed images 
using multiphase CTA or dynamic CTA may be helpful in reduc-
ing overestimation due to the backflow issue.34 In addition, ac-
curate measurements of length either on NCCT or CTA/MRA are 
limited in curved or branched arteries. In cases with different ar-
terial diameters, thrombus length may not precisely represent 
the actual burden of thrombus (Figure 1). Due to these limita-
tions, the determination of thrombus length is usually limited to 
the MCA M1 segment in most cases.
Clot burden score
The clot burden score is a 10-point scoring system to quantify 
the thrombus burden for anterior circulation. For scoring, major 
arteries are allotted for the presence of contrast opacification on 
CTA. One or two points are subtracted for the absence of con-
trast opacification in the infraclinoid internal carotid artery (ICA) 
(2), supraclinoid ICA (2), proximal M1 (2), distal M1 (2), M2 
branches (one each), and A1 (1).36 This scoring system provides 
easy and rapid, yet only approximate, information on thrombus 
burden and can be used for the occlusion in anterior circulation 
only. The clot burden score is also influenced by the backflow 
from collateral circulation; hence, clot burden may be overesti-
mated in cases with insufficient collaterals.2 However, overesti-
mated clot burden because of the lack of contrast filling due to 
poor collaterals may strengthen the prognostic value of this clot 
burden score because poor collaterals are known to be associat-
ed with poor outcomes.2   
Prediction of recanalization based on 
the thrombus density
Thrombus density on CT may reflect the constituents of the 
thrombus to some extent. Red blood cells (RBCs) in the throm-
bus increase attenuation on CT. A hyperdense artery sign is seen 
more commonly in RBC-dominant or mixed thrombi than in fi-
brin-rich thrombi.37,38 RBC-rich thrombi are also seen on MRI. 
The RBC components in thrombi induce ferromagnetic field dis-
tortion, which results in a blooming artifact on GRE and SWI. 
Thrombi are traditionally differentiated into “red thrombi” or 
RBC-fibrin-rich thrombi and “white thrombi” or platelet-fibrin-
rich thrombi. It is assumed that the constituents of thrombi dif-
fer in large artery atherosclerosis and in cardioembolism because 
they have different mechanisms of thrombus formation. The in-
troduction of mechanical thrombectomy has allowed the com-
parison of the histological features of retrieved thrombi from pa-
tients with acute stroke. Earlier studies compared thrombi using 
hematoxylin-eosin staining and found no histological difference 
between arterial and cardiac thrombi.38,39 Subsequent studies 
used hematoxylin-eosin and special or immunohistochemical 
staining to define the constituents of thrombi more distinctly. 
However, findings were inconsistent among studies on RBC 
dominance in arterial thrombi40-42 or cardiac thrombi43,44 (Supple-
mentary Table 1). 
The microscopic distribution of platelets and fibrin within the 
thrombus may be different between arterial and cardiac thrombi. 
In arterial thrombi, RBC masses are located in the center with a 
thin outer covering of fibrin-platelet and platelet aggregates in 
the edge of the thrombi. However, in cardiac thrombi, platelet 
aggregates are scattered throughout the thrombi with large 
amounts of fibrin.41 Although the simple average of thrombus 
HU does not provide consistent information on the prediction of 
thrombus histology and the origin of thrombi (cardiac or arteri-
al), higher HU on CT may suggest a higher proportion of RBC in 
the thrombus. However, a blooming artifact on MRI can provide 
information on the presence of thrombus only. 
Different thrombus characteristics may affect the response to 
IV tPA. Previous studies showed that thrombus density (HU) is 
predictive of recanalization (Table 4). Successful recanalization 
was achieved more frequently in patients with thrombi of higher 
HU than those of lower HU after IV tPA or endovascular treat-
ment.19,26,45-47 However, in studies that assessed the degree of 
thrombus resolution on thin-section NCCT taken before and af-
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ter IV tPA infusion, the thrombus density was not associated 
with the degree of thrombus resolution.32,48 As mentioned earlier, 
the proportion and distribution of each component in thrombus 
are quite heterogeneous. In addition, recanalization is influenced 
by other factors including thrombus volume and the degree of 
collaterals. Therefore, further studies are necessary to ascertain 
Table 4. Thrombus density on CT and recanalization
Thickness
(mm)
Method of ROI drawing
Recanalization 
assessment
Treatment 
modality
Patient 
No.
Recanalization mean±SD HU (relative HU*)
Yes No
P-value
(cut-off†)
Kim, 200619 1.25 Automatic Within 1 day IVT 8 55±3.2 48.4±3.2 0.043
IAT 12 53.8±2.9 49.5±2.4 0.025
IVT+IAT 14 53.2±2.7 47.3±2.9 0.009
(<49.5)
Puig, 201145 3.0 Manually outlined the margin 1 hour IVT 45 49.3 
(1.57±0.23)
42.1 
(1.11±0.15)
<0.001 
(<1.382)
Moftakhar, 201246 2.5 Manually drawn within thrombus Not specified IVT 45 1.58 1.39 0.01
IAT 43 1.66 1.4 0.006
IVT+EVT 77 1.7 1.3 <0.0001
Mokin, 201426 5.0 Manually outlined the margin at EVT IVT+stent 41 49.9±7.6
(1.2±0.2)
43.8±6.6 
(1.0±0.1)
0.01
0.03
Nielsten, 201447 1.0 Manually drawn small circles 1-5 days IVT 88 63.1±10.7 
(1.54±0.23)
52.2±9.5 
(1.29±0.20)
<0.0001
(<56.5, <1.38)
Spiotta, 201425 4.8 Manually drawn small circles at EVT IVT/IAT
IVT+Penumbra
137 57.1±16.3 68.7±43.2 0.22
CT, computed tomography; SD, standard deviation; ROI, region of interest; HU, hounsfield unit; IVT, intravenous thrombolysis; IAT, intra-arterial thrombolysis; 
EVT, endovascular treatment.
*Relative HU is calculated as HU of symptomatic side/HU of asymptomatic side; †Cut-off for persistent occlusion.
Figure 2. A representative case with perviousness. A 78-year-old man who presented with right-side weakness and sensory aphasia. Non-enhanced 
CT shows a “hyperdense” thrombus (arrowhead) in the bifurcation of the left middle cerebral artery (MCA), which corresponds to the occlusion on 
computed tomography angiography (CTA) (arrowhead) (A, B). Dynamic CTA shows gradual enhancement in the thrombus (arrowheads). This gradual 
enhancement indicates the perviousness of a contrast agent into the thrombus (C). Intravenous tissue plasminogen activator (tPA) was administered 
after obtaining dynamic CTA. Digital subtraction angiography taken 2 hours after tPA demonstrates complete recanalization of left MCA (D).
A B
C D
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the role of averaged density of thrombus on NCCT in predicting 
recanalization. 
In a recent study, thrombus density was simultaneously mea-
sured on thin-section NCCT and CTA.49 Then, the perviousness of 
thrombus was determined by calculating the increase in HU on 
CTA compared with NCCT. The increase in HU ≥23 was associ-
ated with recanalization after IV tPA treatment.49 Perviousness to 
the contrast agent may reflect less compact thrombi that are 
more pervious to tPA, which could enhance the action of tPA 
within the thrombi (Figure 2). Thus, the comparison of simulta-
neously measured densities of thrombi on NCCT and CTA may be 
helpful in predicting the response to tPA.   
Practical considerations for the 
measurement of thrombus density
Thrombus density on NCCT has been measured using different 
methods. To calculate density, the ROI should be defined. The 
thrombus margin was defined by manually outlining the margin 
of thrombus in each section. Then, the values of HU in each sec-
tion were summed and divided by the total number of sections.45 
This method is difficult to perform in a clinical setting and may 
underestimate the density since low attenuated areas in the pe-
ripheral area of the thrombus might be included when manually 
outlining the thrombus. In another study, small circles were 
manually drawn three times within the thrombus, and their 
mean values were calculated.47 This method is easy but may 
overestimate the density. 
The prediction of recanalization using the average value of 
thrombus density should rely on how the density is measured. 
The distribution of RBCs, fibrin, and platelets within the throm-
bus are quite heterogeneous among patients and stroke sub-
types.41 In fact, thrombi of arterial origin show a thin outer cov-
ering of platelet-fibrin and a zone of platelet aggregation at the 
edge or periphery of the thrombus.41 While responses to recana-
lization treatment in platelet-rich areas may be different from 
RBC-fibrin rich areas, platelet-fibrin area, or zone within the 
thrombus may be missed by manually defining the area. There-
fore, the entire area of thrombus should be included for averag-
ing HU. While defining the ROI is critical for the accurate calcu-
lation of mean HU, it is not easy to manually outline the margin 
of thrombi precisely. Thus, the prediction of recanalization based 
on thrombus density has some practical limitations for accurate 
measurements, which needs careful attention for the interpreta-
tion of findings in previous studies. These limitations can be 
overcome substantially by using 3-dimensional software, which 
automatically defines the ROI based on the HU of pixels so that 
the entire area of thrombus can be included and averaged. 
Thrombus imaging to determine the 
efficacy of thrombolytic drugs 
The degree of thrombus resolution is a direct indicator of the 
efficacy of thrombolytic drugs. The effect of IV tPA has been de-
termined by quantitatively assessing the changes in thrombus 
volume using 3-dimensional software on NCCT before and after 
IV tPA infusion.32,48 The median volume decreased by 20%, and 
thrombus was completely resolved in 8% of patients after tPA 
infusion. The thrombus resolution increased by 9% per 10 mg 
increment of tPA, indicating that the degree of thrombus resolu-
tion was associated with the total dose of tPA.48 The effect of 
tPA is also time-dependent. The probability of thrombus resolu-
tion was inversely correlated with the time from symptom onset 
to tPA treatment. These findings shed light on the importance of 
time course in IV tPA treatment. Earlier treatment is important 
not only for the rescue of tissues but also for better thrombus 
resolution. Hence, “Time is clot as well as brain.”
Of note, thrombus volume paradoxically increased in about 
20% of patients.48 The reason for this paradoxical increase in 
thrombus volume after tPA treatment is still speculative. Howev-
er, reocclusion after initially successful recanalization occurs in 
about 14-34% of patients treated with IV thrombolysis.50-54 The 
mechanism of reocclusion is associated with paradoxical activa-
tion of platelets and thrombin by tPA.55 Reocclusion is more 
common in cases with residual thrombus.51 Some thrombi, in-
cluding platelet-rich thrombi, may be resistant to tPA, which is 
fibrin-specific. The increase in thrombus volume after tPA treat-
ment may be associated with tPA-induced paradoxical activa-
tion of platelets and generation of thrombin in patients with 
tPA-resistant thrombi. 
Conclusions and perspectives
Imaging of thrombus has evolved from a mere diagnostic 
technique for the presence of clots in intracranial arteries to a 
quantitative and qualitative assessment tool. In addition, further 
understanding of the clot histology and comparison of thrombus 
imaging are now possible as we can get actual thrombi using 
clot-retrieval devices. Several methods have been suggested to 
assess the thrombus. However, measured thrombus volume and 
density differ with the methods used. Thus, it is necessary to un-
derstand the pitfalls of each measurement method. Quantitative 
and qualitative information on thrombi can help predict recana-
lization after IV tPA and endovascular treatment. Direct endo-
vascular treatment without IV tPA treatment can be considered 
in cases with large thrombi that are predicted not to be recana-
lized by IV tPA. Sequential measurements of thrombus volume 
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before and after thrombolytic treatment are also useful to test 
the efficacy of new drugs. However, a standardized method to 
measure the thrombus is necessary for thrombus imaging to be 
used more widely and reliably. Furthermore, if thrombus imaging 
is to be used in clinical practice for predicting recanalization af-
ter the reperfusion therapy, physicians should be able to measure 
thrombus volume and density easily and rapidly. Since quantita-
tive measurements of thrombus size and density require soft-
ware, the user interface and availability of software should be 
improved.    
 
References
1. Lee JS, Demchuk AM. Choosing a hyperacute stroke imaging 
protocol for proper patient selection and time efficient endo-
vascular treatment: lessons from recent trials. J Stroke 2015; 
17:221-228.
2. Treurniet KM, Yoo AJ, Berkhemer OA, Lingsma HF, Boers AM, 
Fransen PS, et al. Clot burden score on baseline computerized 
tomographic angiography and intra-arterial treatment effect 
in acute ischemic stroke. Stroke 2016;47:2972-2978.
3. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters 
A, et al. Effects of alteplase beyond 3 h after stroke in the 
Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a 
placebo-controlled randomised trial. Lancet Neurol 2008;7: 
299-309.
4. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, 
et al. A randomized trial of tenecteplase versus alteplase for 
acute ischemic stroke. N Engl J Med 2012;366:1099-1107.
5. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, 
Yassi N, et al. Endovascular therapy for ischemic stroke with 
perfusion-imaging selection. N Engl J Med 2015;372:1109-
1118.
6. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et 
al. A trial of imaging selection and endovascular treatment for 
ischemic stroke. N Engl J Med 2013;368:914-923.
7. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, 
Lindley RL, et al. Recombinant tissue plasminogen activator 
for acute ischaemic stroke: an updated systematic review and 
meta-analysis. Lancet 2012;379:2364-2372.
8. Campbell BC, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD, 
et al. Endovascular stent thrombectomy: the new standard of 
care for large vessel ischaemic stroke. Lancet Neurol 2015;14: 
846-854.
9. Hong KS, Ko SB, Lee JS, Yu KH, Rha JH. Endovascular recanali-
zation therapy in acute ischemic stroke: updated meta-analy-
sis of randomized controlled trials. J Stroke 2015;17:268-281.
10. Gasparian GG, Sanossian N, Shiroishi MS, Liebeskind DS. Imag-
ing of occlusive thrombi in acute ischemic stroke. Int J Stroke 
2014;10:298-305.
11. Kim J, Park JE, Nahrendorf M, Kim DE. Direct thrombus imag-
ing in stroke. J Stroke 2016;18:286-296.
12. Riedel CH, Jensen U, Rohr A, Tietke M, Alfke K, Ulmer S, et al. 
Assessment of thrombus in acute middle cerebral artery oc-
clusion using thin-slice nonenhanced Computed Tomography 
reconstructions. Stroke 2010;41:1659-1664.
13. Kim EY, Lee SK, Kim DJ, Suh SH, Kim J, Heo JH, et al. Detection 
of thrombus in acute ischemic stroke: value of thin-section 
noncontrast-computed tomography. Stroke 2005;36:2745-
2747.
14. Riedel CH, Zoubie J, Ulmer S, Gierthmuehlen J, Jansen O. Thin-
slice reconstructions of nonenhanced CT images allow for de-
tection of thrombus in acute stroke. Stroke 2012;43:2319-2323.
15. Mair G, Boyd EV, Chappell FM, von Kummer R, Lindley RI, 
Sandercock P, et al. Sensitivity and specificity of the hyper-
dense artery sign for arterial obstruction in acute ischemic 
stroke. Stroke 2015;46:102-107.
16. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, et al. Early 
recanalization after intravenous administration of recombinant 
tissue plasminogen activator as assessed by pre- and post-
thrombolytic angiography in acute ischemic stroke patients. 
Stroke 2007;38:192-193.
17. Rha JH, Saver JL. The impact of recanalization on ischemic 
stroke outcome: a meta-analysis. Stroke 2007;38:967-973.
18. Kim EY, Yoo E, Choi HY, Lee JW, Heo JH. Thrombus volume 
comparison between patients with and without hyperattenu-
ated artery sign on CT. AJNR Am J Neuroradiol 2008;29:359-
362.
19. Kim EY, Heo JH, Lee SK, Kim DJ, Suh SH, Kim J, et al. Prediction 
of thrombolytic efficacy in acute ischemic stroke using thin-
section noncontrast CT. Neurology 2006;67:1846-1848.
20. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, 
Deuschl G, Jansen O. The importance of size: successful recan-
alization by intravenous thrombolysis in acute anterior stroke 
depends on thrombus length. Stroke 2011;42:1775-1777.
21. Shobha N, Bal S, Boyko M, Kroshus E, Menon BK, Bhatia R, et 
al. Measurement of length of hyperdense MCA sign in acute 
ischemic stroke predicts disappearance after IV tPA. J Neuro-
imaging 2013;24:7-10.
22. Behrens L, Mohlenbruch M, Stampfl S, Ringleb PA, Hametner 
C, Kellert L, et al. Effect of thrombus size on recanalization by 
bridging intravenous thrombolysis. Eur J Neurol 2014;21:1406-
1410.
23. Rohan V, Baxa J, Tupy R, Cerna L, Sevcik P, Friesl M, et al. Length 
of occlusion predicts recanalization and outcome after intrave-
nous thrombolysis in middle cerebral artery stroke. Stroke 
Heo, et al. Thrombus Imaging to Predict Recanalization
https://doi.org/10.5853/jos.2016.01522 48 http://j-stroke.org
2014;45:2010-2017.
24. Strbian D, Sairanen T, Silvennoinen H, Salonen O, Lindsberg PJ. 
Intravenous thrombolysis of basilar artery occlusion: thrombus 
length versus recanalization success. Stroke 2014;45:1733-
1738.
25. Spiotta AM, Vargas J, Hawk H, Turner R, Chaudry MI, Batten-
house H, et al. Hounsfield unit value and clot length in the 
acutely occluded vessel and time required to achieve throm-
bectomy, complications and outcome. J Neurointerv Surg 2013; 
6:423-427.
26. Mokin M, Morr S, Natarajan SK, Lin N, Snyder KV, Hopkins LN, 
et al. Thrombus density predicts successful recanalization with 
Solitaire stent retriever thrombectomy in acute ischemic stroke. 
J Neurointerv Surg 2014;7:104-107.
27. Jindal G, Miller T, Shivashankar R, Mitchell J, Stern BJ, Yar-
brough K, et al. Relationship of thrombus length to number of 
stent retrievals, revascularization, and outcomes in acute isch-
emic stroke. J Vasc Interv Radiol 2014;25:1549-1557.
28. Soize S, Batista AL, Rodriguez RC, Trystram D, Tisserand M, Turc 
G, et al. Susceptibility vessel sign on T2* magnetic resonance 
imaging and recanalization results of mechanical thrombecto-
my with stent retrievers: a multicentre cohort study. Eur J Neu-
rol 2015;22:967-972.
29. Angermaier A, Michel P, Khaw AV, Kirsch M, Kessler C, Langner 
S. Intravenous thrombolysis and passes of thrombectomy as 
predictors for endovascular revascularization in ischemic 
stroke. J Stroke Cerebrovasc Dis 2016;25:2488-2495.
30. Mokin M, Levy EI, Siddiqui AH, Goyal M, Nogueira RG, Yavagal 
DR, et al. Association of clot burden score with radiographic 
and clinical outcomes following Solitaire stent retriever throm-
bectomy: analysis of the SWIFT PRIME trial. J Neurointerv Surg 
2016. Epub ahead of print.
31. Kosior JC, Idris S, Dowlatshahi D, Alzawahmah M, Eesa M, 
Sharma P, et al. Quantomo: validation of a computer-assisted 
methodology for the volumetric analysis of intracerebral 
haemorrhage. Int J Stroke 2011;6:302-305.
32. Kim YD, Nam HS, Kim SH, Kim EY, Song D, Kwon I, et al. Time-
dependent thrombus resolution after tissue-type plasminogen 
activator in patients with stroke and mice. Stroke 2015;46: 
1877-1882.
33. Mocco J, Zaidat OO, von Kummer R, Yoo AJ, Gupta R, Lopes D, 
et al. Aspiration Thrombectomy After Intravenous Alteplase 
Versus Intravenous Alteplase Alone. Stroke 2016;47:2331-
2338.
34. Yan S, Chen Q, Xu M, Sun J, Liebeskind DS, Lou M. Thrombus 
length estimation on delayed gadolinium-enhanced T1. Stroke 
2016;47:756-761.
35. Weisstanner C, Gratz PP, Schroth G, Verma RK, Kochl A, Jung 
S, et al. Thrombus imaging in acute stroke: correlation of 
thrombus length on susceptibility-weighted imaging with en-
dovascular reperfusion success. Eur Radiol 2014;24:1735-
1741.
36. Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol 
A, et al. Intracranial thrombus extent predicts clinical out-
come, final infarct size and hemorrhagic transformation in 
ischemic stroke: the clot burden score. Int J Stroke 2008;3: 
230-236.
37. Brinjikji W, Duffy S, Burrows A, Hacke W, Liebeskind D, Majoie 
CB, et al. Correlation of imaging and histopathology of throm-
bi in acute ischemic stroke with etiology and outcome: a sys-
tematic review. J Neurointerv Surg 2016. Epub ahead of print.
38. Liebeskind DS, Sanossian N, Yong WH, Starkman S, Tsang MP, 
Moya AL, et al. CT and MRI early vessel signs reflect clot com-
position in acute stroke. Stroke 2011;42:1237-1243.
39. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Li-
ebeskind D, et al. Analysis of thrombi retrieved from cerebral 
arteries of patients with acute ischemic stroke. Stroke 2006; 
37:2086-2093.
40. Niesten JM, van der Schaaf IC, van Dam L, Vink A, Vos JA, 
Schonewille WJ, et al. Histopathologic composition of cerebral 
thrombi of acute stroke patients is correlated with stroke sub-
type and thrombus attenuation. PLoS One 2014;9:e88882.
41. Ahn SH, Hong R, Choo IS, Heo JH, Nam HS, Kang HG, et al. 
Histologic features of acute thrombi retrieved from stroke pa-
tients during mechanical reperfusion therapy. Int J Stroke 2016; 
11:1036-1044.
42. Boeckh-Behrens T, Kleine JF, Zimmer C, Neff F, Scheipl F, 
Pelisek J, et al. Thrombus histology suggests cardioembolic 
cause in cryptogenic stroke. Stroke 2016;47:1864-1871.
43. Sato Y, Ishibashi-Ueda H, Iwakiri T, Ikeda Y, Matsuyama T, 
Hatakeyama K, et al. Thrombus components in cardioembolic 
and atherothrombotic strokes. Thromb Res 2012;130:278-280.
44. Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS. Histologic 
analysis of retrieved clots in acute ischemic stroke: correlation 
with stroke etiology and gradient-echo MRI. AJNR Am J Neu-
roradiol 2015;36:1756-1762.
45. Puig J, Pedraza S, Demchuk A, Daunis IEJ, Termes H, Blasco G, 
et al. Quantification of thrombus hounsfield units on noncon-
trast CT predicts stroke subtype and early recanalization after 
intravenous recombinant tissue plasminogen activator. AJNR 
Am J Neuroradiol 2011;33:90-96.
46. Moftakhar P, English JD, Cooke DL, Kim WT, Stout C, Smith 
WS, et al. Density of thrombus on admission CT predicts revas-
cularization efficacy in large vessel occlusion acute ischemic 
stroke. Stroke 2012;44:243-245.
47. Niesten JM, van der Schaaf IC, van der Graaf Y, Kappelle LJ, 
https://doi.org/10.5853/jos.2016.01522 
Vol. 19 / No. 1 / January 2017
http://j-stroke.org 49
Biessels GJ, Horsch AD, et al. Predictive value of thrombus at-
tenuation on thin-slice non-contrast CT for persistent occlu-
sion after intravenous thrombolysis. Cerebrovasc Dis 2014;37: 
116-122.
48. Nam HS, Kim EY, Kim SH, Kim YD, Kim J, Lee HS, et al. Predic-
tion of thrombus resolution after intravenous thrombolysis as-
sessed by CT-based thrombus imaging. Thromb Haemost 2012; 
107:786-794.
49. Santos EM, Dankbaar JW, Treurniet KM, Horsch AD, Roos YB, 
Kappelle LJ, et al. Permeable thrombi are associated with high-
er intravenous recombinant tissue-type plasminogen activator 
treatment success in patients with acute ischemic stroke. 
Stroke 2016;47:2058-2065.
50. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke pa-
tients treated with intravenous tissue plasminogen activator. 
Neurology 2002;59:862-867.
51. Heo JH, Lee KY, Kim SH, Kim DI. Immediate reocclusion follow-
ing a successful thrombolysis in acute stroke: a pilot study. 
Neurology 2003;60:1684-1687.
52. Janjua N, Alkawi A, Suri MF, Qureshi AI. Impact of arterial re-
occlusion and distal fragmentation during thrombolysis among 
patients with acute ischemic stroke. AJNR Am J Neuroradiol 
2008;29:253-258.
53. Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani 
JF, et al. Reocclusion of recanalized arteries during intra-arte-
rial thrombolysis for acute ischemic stroke. AJNR Am J Neuro-
radiol 2004;25:322-328.
54. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, 
et al. Clinical deterioration after intravenous recombinant tis-
sue plasminogen activator treatment: a multicenter transcra-
nial Doppler study. Stroke 2007;38:69-74.
55. Lee KY, Heo JH, Lee SI, Yoon PH. Rescue treatment with abcix-
imab in acute ischemic stroke. Neurology 2001;56:1585-1587.
Heo, et al. Thrombus Imaging to Predict Recanalization
https://doi.org/10.5853/jos.2016.01522 http://j-stroke.org
Supplementary Figure 1. Diagnosis of thrombus in imaging studies. (A) Hyperdense artery sign on CT scan (arrowhead), (B) Blooming artifact on the 
susceptibility-weighted image (arrowhead), and (C) Occlusion on CT angiography (arrowhead). CT-Computed Tomography.
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Supplementary Table 1. Thrombus histology according to the stroke subtypes
Author, year
Patient 
No.
Device Staining Analysis
RBC-
dominance
Fibrin/fibrin-plate-
let-dominance
Marder, 20061 25 Merci H&E Feature detection analysis No difference No difference
Liebeskind, 20112 50 Merci H&E Semi-automated quantitation 
   using ImageJ
No difference No difference
Sato, 20123 17 Autopsy FibII, GPIIb/IIIa, glycophorin A Semi-automated quantitation 
   using ImageJ
Cardiac No difference
Niesten, 20144 22 Merci, Trevo, Solitaire H&E, Mallory’s phosphotungstic 
    acid-hematoxylin, glycophorin 
A, CD31
Quantitation by consensus Arterial No differences
Kim, 20155 37 Solitaire, Aspiration platelet glycoprotein IIIa, CD61 Semi-automated quantitation 
   using ImageJ
Cardiac Arterial (fibrin)
Ahn, 20166 32 Aspiration H&E, Martius scarlet blue, CD42b Quantitation by software Arterial Cardiac (fibrin)*
H&E, hematoxylin and eosin; RBC, Red blood cell.
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